Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From Germany.

Document type:: Letter; Journal Article
Author(s):: Braitsch, Krischan; Schmalbrock, Laura K; Jung, Paul; Bumeder, Irmgard; Kiewe, Philipp; Hecker, Judith S; Verbeek, Mareike; Westermann, Jörg; Bullinger, Lars; Keller, Ulrich; Bassermann, Florian; Krönke, Jan; Götze, Katharina S; Rieger, Kathrin
Title:: Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From Germany.
Journal title abbreviation:: Hemasphere
Year:: 2022
Journal volume:: 6
Journal issue:: 9
Fulltext / DOI:: doi:10.1097/HS9.0000000000000759
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/35966764
TUM Institution:: Klinik und Poliklinik für Innere Medizin III, Hämatologie und Onkologie
BibTeX

Occurrences: